Albert Yehaskel joined the EAS network as an Independent Consultant in 2015 and became an Advisor in 2017. He is an accomplished professional with a distinguished record in pharmaceutical regulatory affairs activities. Mr. Yehaskel has been consulting since 2010 and spent 41 years in industry, serving as vice president of regulatory affairs, compliance and safety at Indigo Pharmaceuticals, Inc., and in regulatory roles at Shionogi USA, Sankyo Pharma Development, Purdue Pharma and Sanofi Winthrop. Mr. Yehaskel assists clients with the development, review and submission of pharmaceutical submissions to FDA.
Independent Advisor, Pharmaceutical Submissions